Efficacy and Safety of Switching From Boosted Lopinavir to Boosted Atazanavir in Patients With Virological Suppression Receiving a LPV/r-Containing HAART: The ATAZIP Study
暂无分享,去创建一个
D. Podzamczer | B. Clotet | J. Gatell | J. Mallolas | E. Martinez | J. Blanco | A. Milinkovic | F. Vidal | J. Cosín | E. Lazzari | E. Ferrer | I. García | J. Murillas | E. Pedrol | P. Domingo | F. Gutiérrez | H. Knobel | J. Llibre | E. Ribera | J. Pich | D. Dalmau | J. A. Arranz | V. Roca | M. Aranda | A. Cruceta